Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method for inducing immune response against middle east respiratory syndrome-corona virus using trimeric S1-CD40L fusion protein

Method for inducing immune response against middle east respiratory syndrome-corona virus using trimeric S1-CD40L fusion protein

US Patent 11660334 · Granted May 30, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic plasmid DNA vaccine expressing a codon-optimized SARS-COV-2 spike prot2023
Polynucleotide encoding trimeric S1-CD40L fusion protein immunogen against middl2022
MERS-CoV vaccine composition2022
Nucleic acid based vaccine against middle east respiratory syndrome-coronavirus2022
Intranasal MERS-CoV vaccine2022
MERS-CoV vaccine with trimeric S1-CD40L fusion protein2021
Trimeric S1-CD40L fusion protein vaccine against Middle East respiratory syndrom2020
Composition and method for treating MERS2020